In contrast, miR-181a is considered a CS oncogene, as it is more expressed in high-grade CS; it is up-regulated by hypoxia, increasing vascular endothelial growth factor (VEGF) expression by targeting regulator of G-protein signaling 16 (RGS16). Here, RGS16 is linked to Cowden syndrome 1.